Daniel S. Chen, Yoav Soen, Tor B. Stuge, Peter P. Lee, Jeffrey S. Weber, Patrick O. Brown, ...
Patients vaccinated with melanoma-associated peptides show a wide diversity of responses, analysis of which may help us understand the differing clinical responses to such vaccines.
Daniel S. Chen, Yoav Soen, Tor B. Stuge, Peter P. Lee, Jeffrey S. Weber, Patrick O. Brown, ...
Background In contrast to many animal model studies, immunotherapeutic trials in humans suffering from cancer invariably result in a broad range of outcomes, from long-lasting remissions to no...
Diversity and Recognition Efficiency of T Cell Responses to Cancer (2004)
Tor B. Stuge, Susan P. Holmes, Sahdev Saharan, Andrea Tuettenberg, Mario Roederer, Jeffrey S. Weber, ...
State-of-the art analysis of patients' response to melanoma vaccines yields lessons about cancer vaccines and rationale vaccine design in general.
Diversity and Recognition Efficiency of T Cell Responses to Cancer (2004)
Tor B. Stuge, Susan P. Holmes, Sahdev Saharan, Andrea Tuettenberg, Mario Roederer, Jeffrey S. Weber, ...
Background Melanoma patients vaccinated with tumor-associated antigens frequently develop measurable peptide-specific CD8+ T cell responses; however, such responses often do not confer clinical...
Diversity and Recognition Efficiency of T Cell Responses to Cancer
Stuge, Tor B, Holmes, Susan P, Saharan, Sahdev, Tuettenberg, Andrea, Roederer, Mario, Weber, Jeffrey S, ...
State-of-the art analysis of patients' response to melanoma vaccines yields lessons about cancer vaccines and rationale vaccine design in general
Chen, Daniel S, Soen, Yoav, Stuge, Tor B, Lee, Peter P, Weber, Jeffrey S, Brown, Patrick O, ...
Patients vaccinated with melanoma-associated peptides show a wide diversity of responses, analysis of which may help us understand the differing clinical responses to such vaccines.
Diversity and Recognition Efficiency of T Cell Responses to Cancer
Stuge, Tor B, Holmes, Susan P, Saharan, Sahdev, Tuettenberg, Andrea, Roederer, Mario, Weber, Jeffrey S, ...
State-of-the art analysis of patients' response to melanoma vaccines yields lessons about cancer vaccines and rationale vaccine design in general
Chen, Daniel S, Soen, Yoav, Stuge, Tor B, Lee, Peter P, Weber, Jeffrey S, Brown, Patrick O, ...
Patients vaccinated with melanoma-associated peptides show a wide diversity of responses, analysis of which may help us understand the differing clinical responses to such vaccines.